GFP+ MLL-AF9-induced blast cells from primary leukaemic mice35 were injected into non-irradiated secondary recipient mice, which consistently developed high leukaemia burden within 3.5 weeks from injection (Fig. 1a). Here, KMT2A is linked to leukemia.